EUVIMEDEUVIMED entdecken
Crossref

Development of dynamic prediction models for venous thromboembolism recurrence and bleeding risks to guide personalized anticoagulant therapy

Jonghyun Jeong, Young-Mi Ah, Ji Min Han, Sangil Min, Jaekyu Shin, Kyu-Nam Heo, Ju-Yeun Lee

Journal of Thrombosis and Haemostasis · 2026-05 · 24 (5) · 1747-1758

DOI: 10.1016/j.jtha.2026.01.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-05. Verfasst von Jonghyun Jeong und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Venous Thromboembolism, Anticoagulants, Hemorrhage, Precision Medicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Ministry of Science and ICT, South Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Oral anticoagulants are commonly used for venous thromboembolism (VTE), but the optimal treatment duration remains uncertain, highlighting the need for personalized strategies based on individual risk. OBJECTIVES: We developed predictive models to assess VTE recurrence and major bleeding risks during and after anticoagulant treatment, incorporating time-varying data. METHODS: This study included 14,653 patients with VTE who received oral anticoagulants between July 2018 and December 2020 using a claims database. Two cohorts were constructed: an on-treatment cohort, segmented into 90-day intervals for dynamic updates, and an off-treatment cohort. VTE and major bleeding were identified using diagnosis codes, hospitalization records, and procedure data. Three predictive models were developed: models 1 and 2 predicted 90-day risks of VTE recurrence and major bleeding during treatment, and model 3 predicted VTE recurrence after discontinuation. Time-varying effects were identified through interaction-term testing. Models were developed using least absolute shrinkage and selection operator regression, with optimism-corrected areas under the receiver operating characteristic curves (AUROCs) assessed via bootstrapping. RESULTS: The incidence proportions were 2.7% for on-treatment VTE recurrence, 1.3% for major bleeding, and 0.8% for VTE recurrence within 90 days after discontinuation. The final models showed optimism-corrected AUROCs of 0.715, 0.828, and 0.679 for models 1, 2, and 3, respectively. Calibration was suboptimal for models 2 and 3. CONCLUSION: These models may provide supportive information for individualized treatment decisions to dynamically assess VTE recurrence and bleeding risks, but their clinical value must be confirmed through external validation and recalibrated in larger cohorts before clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismAnticoagulantsHemorrhagePrecision MedicineDecision Support TechniquesHumansRecurrenceFemaleMaleRisk AssessmentMiddle AgedRisk FactorsAgedTime FactorsPrediction AlgorithmsPredictive Value of TestsAdministration, OralTreatment OutcomeAdultDatabases, FactualRetrospective Studies

Stichwörter der Autor:innen

anticoagulantshemorrhagepredictionthromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
  • College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea.
  • Department of Surgery, Seoul National University Hospital, Seoul, Korea; Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Clinical Pharmacy, University of California, San Francisco, San Franciso, California, USA.
  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Electronic address: bogopa8@snu.ac.kr.

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea
  • Ministry of Health and Welfare

Zitieren

APA

Jeong, J., Ah, Y. M., Han, J. M., Min, S., Shin, J., Heo, K. N., & Lee, J. Y. (2026). Development of dynamic prediction models for venous thromboembolism recurrence and bleeding risks to guide personalized anticoagulant therapy. Journal of Thrombosis and Haemostasis, 24(5), 1747-1758. https://doi.org/10.1016/j.jtha.2026.01.018

Vancouver

Jeong J, Ah YM, Han JM, Min S, Shin J, Heo KN, et al. Development of dynamic prediction models for venous thromboembolism recurrence and bleeding risks to guide personalized anticoagulant therapy. Journal of Thrombosis and Haemostasis. 2026;24(5):1747-1758. doi:10.1016/j.jtha.2026.01.018

BibTeX
@article{Jeong2026,
  author = {Jeong, Jonghyun and Ah, Young-Mi and Han, Ji Min and Min, Sangil and Shin, Jaekyu and Heo, Kyu-Nam and Lee, Ju-Yeun},
  title = {Development of dynamic prediction models for venous thromboembolism recurrence and bleeding risks to guide personalized anticoagulant therapy},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {1747--1758},
  doi = {10.1016/j.jtha.2026.01.018}
}
Kostenlos starten →